Call (289) 812-0046
Clinical Trial
For adults (≥18) with moderate to severe hidradenitis suppurativa (subcutaneous study drug)
RECRUITING
Phase 3 | Injection | 52 weeks
CLINICAL TRIAL
Trial ID: NCT06468228
Trial ID: NCT06603077
Phase 2 | Injection | 14 weeks
Trial ID: NCT05889182
Phase 3 | Oral tablet | 88 weeks
Trial ID: NCT06799000
Phase 3 | Oral tablet | 52 weeks